Interestingly, DHMEQ treatment significantly reduced the number of intestinal tumors (63.5 ± 3.0, n = 6) in HAI-1-deficient ApcMin/+ mice to a level comparable with that in control ApcMin/+ mice (Figure 2C). This evidence concerns the gene SPINT1 and intestinal neoplasm.